Clinical Trial Update: S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of erlotinib and bevacizumab in never-smokers with stage IIIB/IV non-small cell lung cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-09-07